| Jun 24 |
The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine
|
| Jun 23 |
DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
|
| Jun 22 |
Gilead Records Positive Phase III Results In HIV
|
| Jun 21 |
Why A Broken Wing Butterfly Might Make Money In Gilead Sciences Stock
|
| Jun 21 |
US indexes open mixed, pharmaceutical stocks climb: Morning Brief
|
| Jun 21 |
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
|
| Jun 21 |
Why Gilead Sciences Stock Is Trading Higher Friday
|
| Jun 21 |
Biggest stock movers: PLTR, ASAN, SWBI, and more
|
| Jun 21 |
Gilead sees encouraging results from shot to prevent HIV
|
| Jun 21 |
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
|
